Savara's lead program is under FDA review, and the company uses LinkedIn for its professional presence.
1 report, 1 independent
Updated Jul 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Savara's lead program is under FDA review, and the company uses LinkedIn for its professional presence.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Savara (Denmark)
company in Hørsholm, Denmark
Nothing else this week.
- FDA
-
LinkedIn
American social networking website for people in professional occupations
Related events
- EMA validated marketing authorization and FDA accepted NDA for Pharvaris N.V.'s lead drug.
- Edgewise Therapeutics announced news from Boulder, Colorado, and utilizes LinkedIn for its public communication.
- An institute is providing marketing tools to enhance professional visibility, utilizing LinkedIn.
- IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.
Coverage
Newest first; wire copies grouped- Business WireSavara Announces New Employment Inducement Grant LANGHORNE, Pa., July 18, 2025--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory dis